Flamel Technologies

Venissieux, France Founded: 1990 • Age: 36 yrs Acquired By Recipharm
Formulation drug delivery company developing drugs for anaesthesia, CNS, respiratory diabetes disorders
Request Access

About Flamel Technologies

Flamel Technologies is a company based in Venissieux (France) founded in 1990 by Gerard Soula was acquired by Recipharm in November 2014.. Flamel Technologies has completed 1 acquisition, including FSC Pediatrics.

  • Headquarter Venissieux, France
  • Founders Gerard Soula
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $15 M (USD), Debt – Venture

    Feb 07, 2013

  • Investors
    Recipharm

    & 1 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Recipharm

    (Nov 01, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Flamel Technologies

  • Total Funding
  • Total Rounds 1
  • Last Round Debt – Venture — $15.0M
  • First Round

    (07 Feb 2013)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2013 Amount Debt – Venture - Flamel Technologies Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Flamel Technologies

Flamel Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Recipharm and Deerfield. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Healthcare ecosystem is supported through investment and innovation by Deerfield.
Founded Year Domain Location
Pharmaceutical development and manufacturing services are offered contractually.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Flamel Technologies

Flamel Technologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include FSC Pediatrics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Pediatric healthcare services are provided in Charlotte.
2004
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Flamel Technologies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Flamel Technologies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Flamel Technologies

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Flamel Technologies

Frequently Asked Questions about Flamel Technologies

When was Flamel Technologies founded?

Flamel Technologies was founded in 1990 and raised its 1st funding round 23 years after it was founded.

Where is Flamel Technologies located?

Flamel Technologies is headquartered in Venissieux, France. It is registered at Venissieux, Auvergne-rhone-alpes, France.

Who is the current CEO of Flamel Technologies?

Gerard Soula is the current CEO of Flamel Technologies. They have also founded this company.

What does Flamel Technologies do?

Flamel Technologies is a specialty pharmaceutical company focussed in the formulation development and drug delivery to develop pharmaceutical products. It currently has 3 drugs in the USA for anesthesia namely Bloxiverz (neostigmine methylsulfate injection), Vazculep (phenylephrine hydrochloride injection) and Akovaz (ephedrine sulfate). Using its proprietary drug delivery platforms Micropump (oral sustained release microparticles platform), LiquiTime (a Micropump-derivative platform for liquid oral products) and Trigger Lock (a Micropump-derivative platform for abuse-resistant opioids), it is also developing its pipeline for CNS respiratory disorders which include sodium oxybate, an extended-release of liquid medicines such as ibuprofen and guaifenesin and also working on the delivery of exenatide utilizing the Medusa technology for diabetes. It acquired Eclat Pharmaceuticals FSC Pediatrics in March 2012 February 2016 respectively.

How many acquisitions has Flamel Technologies made?

Flamel Technologies has made 1 acquisition, including FSC Pediatrics.

Who are Flamel Technologies's investors?

Flamel Technologies has 2 investors. Key investors include Recipharm, and Deerfield.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available